InvestorsHub Logo
Followers 14
Posts 1731
Boards Moderated 0
Alias Born 04/07/2014

Re: Steve43 post# 173333

Monday, 03/04/2019 11:36:36 AM

Monday, March 04, 2019 11:36:36 AM

Post# of 329291
Well, IMO, BIEL has more than 10 years to formulate, at least, an adequate distribution process for its product(s). I extracted two paragraphs from the NHS study on comprehensive costs & benefits factors relating to the use of Actipatch, see below.

"Decreases in pain and quality of life improvement associated with ActiPatch use also reduced financial burden to the NHS, associated with providing healthcare services. Utilization of healthcare services, such as visits to a General Practitioner (GP), pain specialist and/or other healthcare professionals for example physical therapist, were reduced for the entire study group. Additionally, costs associated with prescription analgesic medications was also reduced by a total of £2960, or £98.66 per subject over a 3-month period.

Conclusion:
Introduction of ActiPatch as a chronic pain therapy resulted in significant improvements in patient quality of life, reduced pain medication use and reduced utilization of healthcare services. Incorporating ActiPatch as a standard therapy option for chronic pain sufferers is expected to result in significant cost savings for the NHS."


Good lord, and BIEL is unable to supply and sell this product?! IMHO, all BIEL needs to do is present these two paragraphs in a slick Ad formula, and their troubles are over, overnight! Why this product is not supplied and flying off the selves by now, is an unqualified mystery to me! This is absurd! Something is seriously wrong here folks!!

GLTA!!!

P.S. A "D" student from a third rate marketing school could be highly successful in selling this product. 100:1 on it!